October 24, 2024
Drama, Jealousy and Money
Looking at the current state of the GLP1 market it isn’t so much about science as it is about drama combined with some jealousy all over a huge pot of money. At the moment the two lead characters of this drama are longtime rivals Novo Nordisk and Eli Lilly. There are a host of characters looking to join Novo and Lilly on the GLP1 stage. Yet for the moment the GLP1 market is pretty much a duopoly.
As with any good drama there are multiple sub plots. One of the juicier sub plots is the battle between Novo, Lilly . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
